This evidence suggests that APOE may strongly influence AD risk at younger ages, but as the individuals' age increases, the effect of APOE is reduced and therefore, other risk variants start to play a more fundamental role in AD risk. The gene discussed is APOE; the disease is Alzheimer disease.